Medtronic, Inc. (MDT) PT Lowered to $105 at Piper Sandler After Underwhelming Study Data
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien lowered the price target on Medtronic, Inc. (NYSE: MDT) to $105.00 (from $110.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
